Improving Pancreatic Function With Elexacaftor/Tezacaftor/Ivacaftor

Key Points

• The aim is to investigate the effects of Elexacaftor/Tezacaftor/Ivacaftor therapy on pancreatic function.
• Assessment of pancreatic function before and after ETI therapy.
• Monitoring of FE-1 values over a defined period.
• Significant indications of improved pancreatic function noted.
• Potential reversal of pancreatic insufficiency in subjects.
• Importance of early therapy initiation highlighted.

Abstract